Stay updated on Dara-VCd vs VTd, Maintenance with IXA Clinical Trial

Sign up to get notified when there's something new on the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Major change: update to v3.2.0 and a prominent notice about funding-related accessibility and where to check operating status. Previous v3.1.0 was removed. If no significant changes were detected beyond this, the page now communicates funding-related status and directs users to official status sources.
    Difference
    2%
    Check dated 2025-10-05T09:49:13.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Update term and topic scope from Plasma cell myeloma to Multiple myeloma, and bump page revision from v3.0.2 to v3.1.0 to reflect updated genetics-related content.
    Difference
    0.3%
    Check dated 2025-09-28T03:09:10.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed MedlinePlus Genetics topic on multiple myeloma; core content related to this disease is reduced.
    Difference
    0.1%
    Check dated 2025-09-20T22:04:43.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Update to Revision: v3.0.2 from v3.0.1 and removal of the 'Back to Top' link; overall, a minor maintenance update with no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-13T17:07:00.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T14:43:39.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of new medical terms related to plasma cell myeloma and hemic and lymphatic diseases. Notably, several previously listed drugs and terms have been removed.
    Difference
    3%
    Check dated 2025-08-30T11:28:24.000Z thumbnail image

Stay in the know with updates to Dara-VCd vs VTd, Maintenance with IXA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page.